Thermo Fisher Scientific (TMO) Cash from Operations (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Cash from Operations for 18 consecutive years, with 1192000000.0 the latest figure, recorded in Q1 2026.

• Cash from Operations for Q1 2026 came in at 1192000000.0, up 64.87% year-over-year; the trailing twelve-month figure through Mar 2026 was 8287000000.0 (up 1.82% YoY), and the FY2025 annual result was 7818000000.0, down 9.8% from the prior year.
• Cash from Operations was 1192000000.0 for Q1 2026 at Thermo Fisher Scientific, down from 3457000000.0 in the prior quarter.
• Over five years, Cash from Operations peaked at 3723000000.0 in Q4 2023 and troughed at 723000000.0 in Q1 2025.
• Average Cash from Operations over 5 years is 2072764705.88, with a median of 1960000000.0 recorded in 2024.
• Year-over-year, Cash from Operations plunged 66.89% in 2023 and surged 71.6% in 2024.
• Over 5 years, Cash from Operations stood at 3487000000.0 in 2022, then advanced by 6.77% to 3723000000.0 in 2023, then declined by 11.63% to 3290000000.0 in 2024, then advanced by 5.08% to 3457000000.0 in 2025, then sank by 65.52% to 1192000000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 1192000000.0 in Q1 2026, 3457000000.0 in Q4 2025, and 2239000000.0 in Q3 2025.